CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations

作者：Bin Xue, Yifan Liu, Jie Zhou, Lili Zhou, Shiguang Ye, Yan Lu, Yan Lu, Wenjun Zhang, Bing Xiu, Ping Li, Ying Lü, You Lu, Xiu Luo, Wenbin Qian, Xiu Luo · 发表于：Cytotherapy · 年份：2024 · DOI：10.1016/j.jcyt.2024.07.011 · 被引用次数：14 · 研究领域：CAR-T cell therapy research、Lymphoma Diagnosis and Treatment、Cutaneous lymphoproliferative disorders research